surmount 5 tirzepatide Understanding SURMOUNT-5 trial about using Mounjaro & Wagevovy/Ozempic for weight loss in patients without Tirzepatide after intensive lifestyle intervention

At the top dose, it cut HbA1c by about 2.2% and body weight by about 9.2%, compared to about 1.4% and 5.3% for semaglutide

Some patients also reduce tirzepatide if they experience constipation, fatigue, or hypoglycemia (low blood sugar, especially those on insulin or other diabetes meds)

When considering side effects , Qsymia may present issues such as dizziness or dry mouth, while Zepbound is often associated with gastrointestinal discomfort

R-96544 shows 100-fold higher affinity for the human 5HT 2A receptors than 5HT 1A , 5HT 1B , 5HT 1D , 5HT 5A , 5HT 6 , 5HT 7 receptors and 5-HT transporter, although R-96544 has relatively high affinity for 5HT 2C receptors (fourfold less compared to 5-HT 2A ) (21)

62 pounds down